3rd Quarter - Amendment

SUMITOMO PHARMA AMERICA, INC.(FORMERLY SUNOVION PHARMACEUTICALS INC.) for SUMITOMO PHARMA AMERICA, INC. (FORMERLY SUNOVION PHARMACEUTICALS INC.)

Firm
Client
Income
—
Expenses
$343,953
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 20, 2009 $269,585 Replaced
3rd Quarter - Amendment (this page) Dec 16, 2009 $343,953 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

reimbursement issues related to Medicaid reimbusement

LobbyistCovered position, as disclosed
ENGEL BURNS —
ANTHONY MAGNETTI —
MARK WANDA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.